{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/25/3317395/0/en/Atea-Pharmaceuticals-Completes-Patient-Enrollment-in-Phase-3-C-FORWARD-Trial-Evaluating-Bemnifosbuvir-and-Ruzasvir-for-Treatment-of-Hepatitis-C-Virus.html", "message": "News view counter 816194 successfully enlarged"}